GNRH1 and polycystic ovary syndrome: Despite this lack of group difference, manipulation of testosterone levels (suppression by gonadotropin‐release hormone (GnRH) antagonism, followed by re‐introduction of exogenous testosterone) affected sympathetic baroreflex gain in PCOS but not in controls.